Definitions

from Wiktionary, Creative Commons Attribution/Share-Alike License.

  • noun A human monoclonal antibody under investigation for the treatment of chronic lymphocytic leukemia and other diseases.

Etymologies

from Wiktionary, Creative Commons Attribution/Share-Alike License

-tum- +‎ -u- +‎ -mab

Support

Help support Wordnik (and make this page ad-free) by adopting the word ofatumumab.

Examples

  • Genmab, which is developing the drug with GlaxoSmithKline PLC, said it aims to submit the drug, called ofatumumab, for U.S. and European regulatory approval by the end of this year.

    Genmab's Cancer Treatment 2008

  • "We are committed to the further development of ofatumumab in [non-Hodgkin's lymphoma]," said Genmab Chief Executive Lisa Drakeman.

    Genmab, Glaxo Drug Disappoints in Study 2009

  • Genmab said it and Glaxo will continue to review the results of the non-Hodgkin's lymphoma study and discuss the development strategy for Arzerra in the treatment of the condition, which is also known as ofatumumab.

    Genmab, Glaxo Drug Disappoints in Study 2009

  • About 44% of patients in the other group responded well to ofatumumab.

    Genmab's Cancer Treatment 2008

  • After 24 weeks, 51% of patients in the group not responding to both older medicines experienced a strong response to ofatumumab, Genmab said.

    Genmab's Cancer Treatment 2008

  • All of the patients were given eight weekly infusions of ofatumumab and then four monthly infusions.

    Genmab's Cancer Treatment 2008

  • Glaxo is hoping that ofatumumab will boost its presence in the oncology business, which is growing at a faster rate than other disease areas.

    Genmab's Cancer Treatment 2008

  • We are also evaluating the safety of PCI-32765 in combination with ofatumumab in a Phase IB/II study of patients with relapsed/refractory CLL/SLL.

    unknown title 2011

  • - In July, we announced positive interim data in the ofatumumab Phase II safety and pharmacokinetics study in patients with relapsing-remitting multiple sclerosis (RRMS).

    News 2010

  • Genmab is changing its 2010 financial guidance primarily as a result of the amendment of the ofatumumab co-development and commercialization agreement with GSK.

    News 2010

Comments

Log in or sign up to get involved in the conversation. It's quick and easy.